Medline Shares Drop Sharply After Q2 Results, Analyst Cut and COO Exit Raise Concerns
Medline stock plunged 11.4% in pre-market trading after the company issued its second-quarter 2026 financial materials before the market opened. Investors reacted to earnings details against a recent history of margin compression, a near-term analyst price-target reduction from UBS and the announced retirement of the company's Chief Operating Offic…